Results 251 to 260 of about 242,210 (352)
Corrigendum: Neuroprotection by upregulation of the major histocompatibility complex class I (MHC I) in SOD1G93A mice. [PDF]
Tomiyama ALMR +4 more
europepmc +1 more source
Pharmacokinetic Model Selection for Personalized Infliximab Dosing in IBD
ABSTRACT Infliximab, a monoclonal antibody used for immune‐mediated diseases, shows high interpatient pharmacokinetic variability. Prolonged exposure increases the risk of adverse effects and costs, making dose personalization essential to balance safety, efficacy, and cost‐effectiveness. Population pharmacokinetic models support individualized dosing,
Sahira Chaiben +4 more
wiley +1 more source
New mutations and new phenotypes: a case of Major Histocompatibility Complex Class II Deficiency. [PDF]
Li X, Lu B, Luo X.
europepmc +1 more source
Harnessing Natural Compounds in Psoriasis: Targeting Cellular Pathways for Effective Therapy
Natural compounds act on key cellular pathways in psoriasis by suppressing keratinocyte hyperproliferation, modulating Th17/IL‐17‐mediated immune responses, and reducing oxidative stress. These multi‐target effects highlight their potential as safer adjunctive therapies alongside conventional treatments.
Hye Jin Lee +9 more
wiley +1 more source
Deletion of metal transporter Zip14 reduces major histocompatibility complex II expression in murine small intestinal epithelial cells. [PDF]
Jimenez-Rondan FR +7 more
europepmc +1 more source
Clinical perspectives and comparisons between immunoglobulin G4‐related disease and antineutrophil cytoplasmic antibody‐associated vasculitis. Abstract Both immunoglobulin (Ig) G4‐related disease (IgG4‐RD) and antineutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV) are systemic disorders that affect a wide range of organs.
Wenhuan Zeng, Mingxin Bai, Yanying Liu
wiley +1 more source
Targeted and complete genomic sequencing of the major histocompatibility complex in haplotypic form of individual heterozygous samples. [PDF]
Hu T +10 more
europepmc +1 more source

